Exploring human mammaglobin: as a possible diagnostic and prognostic indicator in breast cancer tissue
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20241311Keywords:
Mammaglobin-A, Prognosis, Breast cancer, TobaccoAbstract
Breast cancer is a major global health issue, with high diagnosis rates worldwide, especially in less developed areas, leading to significant mortality rates. This review focuses on the molecular characteristics of breast cancer, emphasizing the role of human mammaglobin-A (hMAM-A) as a diagnostic and prognostic marker. hMAM-A, a dimeric protein from the secretoglobin family, is produced exclusively by breast tissue and shows elevated levels in breast cancer cases, making it a highly accurate marker for disease detection. The review also examines various factors influencing breast cancer, such as age, tobacco use, menopausal status, and hormone replacement therapy (HRT). Younger age at diagnosis is associated with poorer outcomes, highlighting the importance of early detection. Tobacco smoke increases mortality rates in breast cancer patients. Menopausal status affects molecular subtypes and risk factors, impacting treatment and prognosis. HRT has a complex relationship with breast cancer risk. The review concludes by discussing the need for novel biomarkers, including hMAM-A, to improve breast cancer diagnosis and management.
References
Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):20211033.
Zannetti A. Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0. Int J Mol Sci. 2023;24(3):2542.
Cui Q, Jiang D, Zhang Y, Chen C. The tumor-nerve circuit in breast cancer. Cancer and Metastasis Reviews. 2023;31:1-32.
De Talhouet S, Peron J, Vuilleumier A, Friedlaender A, Viassolo V, Ayme A, et al. Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Scientific Rep. 2020;10(1):7073.
Gorbokon N, Timm P, Dum D, Menz A, Büscheck F, Völkel C, et al. Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland. Diagnostics. 2023;13(6):1202.
Basudan AM. Breast cancer incidence patterns in the Saudi female population: A 17-year retrospective analysis. Medicina. 2022;58(11):1617.
Abo Al-Shiekh SS, Ibrahim MA, Alajerami YS. Breast cancer knowledge and practice of breast self-examination among female university students, Gaza. Scientific World J. 2021;27:2021.
Milosevic B, Stojanovic B, Cvetkovic A, Jovanovic I, Spasic M, Stojanovic MD, et al. The enigma of mammaglobin: redefining the biomarker paradigm in breast carcinoma. Int J Mol Sci. 2023;24(17):13407.
Fatima M, Sai Baba KS, Sreedevi NN, Kumar JP, Raju GS, Uppin SG, et al. Evaluation of Serum Mammaglobin as an Alternative Biomarker in the Diagnosis of Breast Tumors. J Lab Physicians. 2022;15(01):020-4.
Baker E, Whiteoak N, Hall L, France J, Wilson D, Bhaskar P. Mammaglobin-A, VEGFR3, and Ki67 in human breast cancer pathology and five-year survival. Breast Cancer: basic and clinical research. 2019;13:1178223419858957.
Oloomi M, Moazzezy N, Bouzari S. Comparing blood versus tissue-based biomarkers expression in breast cancer patients. Heliyon. 2020;6(4).
Hu Y, Liu P, Wu D, Jiang Y. Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis. OncoTargets Therapy. 2018:3245-55.
El Saghir NS, Khalil LE, El Dick J, Atwani RW, Safi N, Charafeddine M, et al. Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at Diagnosis. JCO Global Oncol. 2023;9:e2200354.
Al-Shamsi HO, Abdelwahed N, Abyad A, Abu-Gheida I, Afrit M, Abu ElFuol T, et al. Breast Cancer in the Arabian Gulf Countries. Cancers. 2023;15(22):5398.
Albeshan SM, Alashban YI. Incidence trends of breast cancer in Saudi Arabia: A joinpoint regression analysis (2004–2016). J King Saud University-Sci. 2021;33(7):101578.
McBride RB, Fei K, Rothstein JH, Alexeeff SE, Song X, Sakoda LC, et al. Alcohol and tobacco use in relation to mammographic density in 23,456 women. Cancer Epidemiol Biomarkers Prev. 2020;29(5):1039-48.
Gali K, Bokemeyer F, Behrens S, Möhl A, Obi N, Becher H, et al. Changes in cigarette smoking behavior among breast cancer and unaffected women–A prospective study in the MARIE cohort. Cancer Epidemiol. 2022;81:102282.
Lai YC, Chen YH, Wu YC, Liang FW, Wang JJ, Lim SW, et al. The Association between Smoking and Mortality in Women with Breast Cancer: A Real-World Database Analysis. Cancers. 2022;14(19):4565.
Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. The Lancet Global Health. 2020;8(8):e1027-37.
Ding YC, Hurley S, Park JS, Steele L, Rakoff M, Zhu Y, et al. Methylation biomarkers of polybrominated diphenyl ethers (PBDEs) and association with breast cancer risk at the time of menopause. Env Int. 2021;156:106772.
Hamoda H, Panay N, Pedder H, Arya R, Savvas M. The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020;26(4):181-209.
Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women’s health initiative randomized clinical trials. JAMA. 2020;324(4):369-80.
